Dominik Paul Modest
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pre-Operative Treatment in REseCTable COlon CanceR (NCT06899477) | Dominik Paul Modest | 2025-04-01 |
| Trifluridine/ Tipiracil Plus Panitumumab Versus Trifluridine/ Tipiracil Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer (NCT05007132) | Dominik Paul Modest | 2021-12-17 |
| Post-resection/Ablation Chemotherapy in Patients With Metastatic Colorectal Cancer (FIRE-9 - PORT / AIO-KRK-0418) (NCT05008809) | Dominik Paul Modest | 2021-12-06 |
Track Dominik Paul Modest automatically
Every clearance here is in the API, with alerts when new ones post.